Wall Street Today in the Buzz

 WallStreetBuzz
 
  WallStreetBuzz
 
Follow  Message
 
 
 
Your pulse on Wall Street! WallStreetBuzz delivers real-time market intelligence, breaking news, and expert analysis. From opening bell to closing bell, we cover major movers, market trends, sector rotation, institutional flows, and the stories moving stocks
 

•  04 Mar 2026
 

•   ANF  
   
  -3.60%
•   COIN  
   
  +14.57%
•   CRWD  
   
  +4.15%
•   GTLB  
   
  -6.18%
•   MRNA  
   
  +15.99%

$MRNA Moderna advances 9% after resolving a major mRNA patent dispute, removing a multiyear litigation overhang. The market reads this as a balance sheet event; it is more structural. Legal clarity reopens optionality around platform monetization and pipeline partnerships at a time when capital is re-pricing duration risk in biotech.

$MSTR Strategy gains 8% alongside a move in bitcoin above $71K, with crypto equities outperforming the underlying. The reflexive bid signals renewed balance sheet beta demand rather than pure spot exposure. Equity leverage to digital assets is being accumulated as a macro hedge against dollar softness.

$COIN Coinbase adds 7% as volumes re-rate with price. What is missed is the correlation shift: crypto equities are trading more tightly with real yields than with the Nasdaq, suggesting positioning for a liquidity inflection rather than speculative retail flow.

$TSLA Tesla trades firm after a Bank of America upgrade citing autonomous leadership and robotaxi optionality. The headline is price target expansion; the deeper signal is institutional willingness to underwrite software multiples within autos again, reversing the early-year rotation away from high-duration growth.

$CRWD CrowdStrike edges higher on guidance slightly above consensus. The muted reaction indicates expectations were already reset; recurring revenue durability in cybersecurity is being treated as quasi-defensive amid geopolitical risk, compressing dispersion within enterprise software.

$WIX Wix advances after mid-teens growth guidance and 20–25% free cash flow margin targets. Buybacks into 2026 suggest capital return discipline. The market underestimates how self-funded growth stories are regaining sponsorship as rate-cut expectations stabilize.

$GTLB GitLab falls 9% on softer forward revenue and EPS outlook. This divergence versus peers highlights selective intolerance for execution risk. Investors are differentiating between profitable growth and aspirational scale, a pattern consistent with late-cycle software repricing.

$ANF Abercrombie & Fitch declines despite a beat, as 2026 growth guidance decelerates and tariff risk pressures margins. The reaction underscores that multiple expansion in discretionary is capped without pricing power, especially with energy volatility back in focus.

View All Headlines